There is a newer version of the record available.

Published May 6, 2020 | Version v1
Journal article

First laser ions at the CERN-MEDICIS facility

  • 1. Ural Federal University. Institute of Physics and Technology (Russian Federation)
  • 2. Johannes Gutenberg-Universität. Institut für Physik (Germany)
  • 3. CERN. EN Department (Switzerland)
  • 4. KU Leuven. Instituut voor Kern- en Stralingsfysica (Belgium)
  • 5. A Novartis Company. Advanced Accelerator Applications (Italy)
  • 6. Nantes University. SUBATECH (France)
  • 7. GIP ARRONAX (France)
  • 8. Gothenburg University (Sweden)

Description

The CERN-MEDICIS facility aims to produce emerging medical radionuclides for the theranostics approach in nuclear medicine with mass separation of ion beams. To enhance the radioisotope yield and purity of collected samples, the resonance ionization laser ion source MELISSA was constructed, and provided the first laser ions at the facility in 2019. Several operational tests were accomplished to investigate its performance in preparation for the upcoming production of terbium radioisotopes, which are of particular interest for medical applications.

Additional details

Identifiers

Publishing Information

Journal Title
Hyperfine Interactions
Journal Volume
241
Journal Issue
1
Journal Page Range
vp.
ISSN
0304-3843
CODEN
HYINDN

Optional Information

Copyright
Copyright (c) 2020 © The Author(s) 2020